PVI
KYNB

Pura Vida Investments’s Kyntra Bio KYNB Stock Holding History

Pura Vida Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,804
Closed -$5.2M – 297
2021
Q2 		$5.2M Buy
+7,804
New +$4.5M 0.16% 115

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Pura Vida Investments's KYNB Position: Q4 2021 in Review

Pura Vida Investments sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 1,395 shares — an estimated $356K sold.

Pura Vida Investments first reported a position in KYNB in Q3 2021 and held it in 1 quarter. The position peaked at $356K in Q3 2021. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Pura Vida Investments reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 1,395 Kyntra Bio shares in Q4 2021, an estimated $356K.
  • Pura Vida Investments first reported a position in Kyntra Bio in Q3 2021 and held it in 1 quarter.
  • Pura Vida Investments's Kyntra Bio position peaked at $356K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.